Cordant’s Prescription Drug Take-Back Program Has Helped Remove More Than 214,000 Pills From Homes DENVER (April 26, 2019) – Cordant Health Solutions™ (Cordant), a provider of innovative tools for monitoring and managing behavioral health and chronic pain patients through its unique pharmacy and drug testing
Cordant Study Finds Patients Continue to Use Alcohol and Prescription Drugs Concurrently, Despite Label Warnings As part of Alcohol Awareness Month, Cordant Health Solutions™ (Cordant), a provider of innovative tools for chronic pain, mental health and workers’ compensation providers through its uniquely integrated drug testing
As providers try to find non-addictive alternatives to opioids to treat pain, prescriptions for off-label use of gabapentin have been climbing. Perhaps best known for treating pain associated with shingles, gabapentin does not show affinity for the same types of receptor sites in the brain
The Centers for Disease Control and Prevention (CDC) has published a new study1 that confirms an increase in drug overdose deaths in 2017 compared with the previous year. The study reveals that of the 70,237 drug overdose deaths in 2017, 47,600 (67.8 percent) involved opioids, representing
Cordant Announces Expanded Mental Health Monitoring Capabilities to Increase Medication Adherence for Chronic Conditions Cordant Health Solutions™, a leading provider of innovative tools for monitoring and managing behavioral health and chronic pain patients through its unique pharmacy and drug testing programs, now offers saliva testing
The use of cannabis as an alternative to opioid therapy is gaining serious consideration. Cannabis, also known as marijuana, is still a federal Schedule I drug, meaning it is an illegal drug considered to have a high abuse potential and no medical use. However, acceptance
DENVER, Nov. 15, 2018 – Cordant Health Solutions™ a provider of innovative tools for monitoring and managing behavioral health and chronic pain patients through its unique pharmacy and drug testing programs, announced that the United States Patent and Trademark Office has issued a patent for Cordant’s
Opioid misuse and abuse is a long-standing and growing concern for workers’ compensation payers. Appropriate monitoring of injured worker compliance with a given treatment plan is an essential missing piece of the treatment puzzle. The Official Disability Guidelines and the American College of Occupational and
The opioid epidemic continues to be at the forefront of the national conversation, and related, worrisome trends are on the horizon. Cordant Health Solutions™ is working alongside providers and payers at the front lines of this battle, implementing strategies to address the epidemic and work